Coffee contains various bioactives implicated with human health and disease risk. To accurately assess the effects of overall consumption upon health and disease, individual intake must be measured in large epidemiological studies. Metabolomics has emerged as a powerful approach to discover biomarkers of intake for a large range of foods. Here we report the profiling of the urinary metabolome of cohort study subjects to search for new biomarkers of coffee intake. Using repeated 24-hour dietary records and a food frequency questionnaire, 20 high coffee consumers (183–540 mL/d) and 19 low consumers were selected from the French SU.VI.MAX2 cohort. Morning spot urine samples from each subject were profiled by high-resolution mass spectrometry. Partial least-square discriminant analysis of multidimensional liquid chromatography-mass spectrometry data clearly distinguished high consumers from low via 132 significant (p-value<0.05) discriminating features. Ion clusters whose intensities were most elevated in the high consumers were annotated using online and in-house databases and their identities checked using commercial standards and MS-MS fragmentation. The best discriminants, and thus potential markers of coffee consumption, were the glucuronide of the diterpenoid atractyligenin, the diketopiperazine cyclo(isoleucyl-prolyl), and the alkaloid trigonelline. Some caffeine metabolites, such as 1-methylxanthine, were also among the discriminants, however caffeine may be consumed from other sources and its metabolism is subject to inter-individual variation. Receiver operating characteristics curve analysis showed that the biomarkers identified could be used effectively in combination for increased sensitivity and specificity. Once validated in other cohorts or intervention studies, these specific single or combined biomarkers will become a valuable alternative to assessment of coffee intake by dietary survey and finally lead to a better understanding of the health implications of coffee consumption.
References
[1]
Ranheim T, Halvorsen B (2005) Coffee consumption and human health - beneficial or detrimental? - Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 49: 274–284. doi: 10.1002/mnfr.200400109
[2]
Butt MS, Sultan MT (2011) Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr 51: 363–373. doi: 10.1080/10408390903586412
[3]
Bohn SK, Ward NC, Hodgson JM, Croft KD (2012) Effects of tea and coffee on cardiovascular disease risk. Food & Function 3: 575–591. doi: 10.1039/c2fo10288a
[4]
Corti R, Binggeli C, Sudano I, Spieker L, Hanseler E, et al. (2002) Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content - Role of habitual versus nonhabitual drinking. Circulation 106: 2935–2940. doi: 10.1161/01.cir.0000046228.97025.3a
[5]
Noordzij M, Uiterwaal C, Arends LR, Kok FJ, Grobbee DE, et al. (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 23: 921–928. doi: 10.1097/01.hjh.0000166828.94699.1d
[6]
Cornelis MC, El-Sohemy A (2007) Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol 18: 13–19. doi: 10.1097/mol.0b013e3280127b04
[7]
Liu JX, Sui XM, Blair SN, Lavie CJ (2013) In Reply-Association of Coffee Consumption With All-Cause and Cardiovascular Disease Mortality. Mayo Clin Proc 88: 1493–1494. doi: 10.1016/j.mayocp.2013.10.003
[8]
van Dam RM (2008) Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab 33: 1269–1283. doi: 10.1139/h08-120
[9]
van Dam RM, Willett WC, Manson JE, Hu FB (2006) Coffee, caffeine, and risk of type 2 diabetes - A prospective cohort study in younger and middle-aged US women. Diabetes Care 29: 398–403. doi: 10.2337/diacare.29.02.06.dc05-1512
[10]
Zhang R, Wang Y, Song B, Jorgensen HS, Xu YM (2012) Coffee consumption and risk of stroke: a meta-analysis of cohort studies. Cent Eur J Med 7: 310–316. doi: 10.2478/s11536-011-0154-6
[11]
Perez-Jimenez J, Fezeu L, Touvier M, Arnault N, Manach C, et al. (2011) Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr 93: 1220–1228. doi: 10.3945/ajcn.110.007096
[12]
Zamora-Ros R, Knaze V, Lujan-Barroso L, Romieu I, Scalbert A, et al. (2013) Differences in dietary intakes, food sources and determinants of total flavonoids between Mediterranean and non-Mediterranean countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr 109: 1498–1507. doi: 10.1017/s0007114512003273
[13]
Higdon JV, Frei B (2006) Coffee and health: A review of recent human research. Crit Rev Food Sci Nutr 46: 101–123. doi: 10.1080/10408390500400009
[14]
Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA (2009) Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet 125: 507–525. doi: 10.1007/s00439-009-0662-5
Pujos-Guillot E, Hubert J, Martin JF, Lyan B, Quintana M, et al. (2013) Mass Spectrometry-based Metabolomics for the Discovery of Biomarkers of Fruit and Vegetable Intake: Citrus Fruit as a Case Study. J Proteome Res 12: 1645–1659. doi: 10.1021/pr300997c
[17]
Briancon S, Boini S, Bertrais S, Guillemin F, Galan P, et al. (2011) Long-term antioxidant supplementation has no effect on health-related quality of life: The randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial. Int J Epidemiol 40: 1605–1616. doi: 10.1093/ije/dyr161
[18]
Kesse-Guyot E, Castetbon K, Touvier M, Hercberg S, Galan P (2011) Relative validity and reproducibility of a food frequency questionnaire designed for French adults. Ann Nutr Metab 57: 153–162. doi: 10.1159/000321680
[19]
Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G (2006) XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78: 779–787. doi: 10.1021/ac051437y
[20]
van der Kloet FM, Bobeldijk I, Verheij ER, Jellema RH (2009) Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. J Proteome Res 8: 5132–5141. doi: 10.1021/pr900499r
[21]
Wold S, Antti H, Lindgren F, Ohman J (1998) Orthogonal signal correction of near-infrared spectra. Chemomtr Intell Lab 44: 175–185. doi: 10.1016/s0169-7439(98)00109-9
[22]
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Stat Method) 57: 289–300.
[23]
Xia JG, Broadhurst DI, Wilson M, Wishart DS (2013) Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 9: 280–299. doi: 10.1007/s11306-012-0482-9
[24]
Ginz M, Engelhardt UH (2000) Identification of proline-based diketopiperazines in roasted coffee. J Agric Food Chem 48: 3528–3532. doi: 10.1021/jf991256v
[25]
Blanchard J, Sawers SJA (1983) The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 24: 93–98. doi: 10.1007/bf00613933
[26]
Yang A, Palmer A, de Wit H (2010) Genetics of caffeine consumption and responses to caffeine. Psychopharmacology 211: 245–257. doi: 10.1007/s00213-010-1900-1
[27]
Lang R, Wahl A, Stark T, Hofmann T (2011) Urinary N-methylpyridinium and trigonelline as candidate dietary biomarkers of coffee consumption. Mol Nutr Food Res 55: 1613–1623. doi: 10.1002/mnfr.201000656
[28]
Al-Habori M, Raman A (1998) Antidiabetic and hypocholesterolaemic effects of fenugreek. Phytother Res 12: 233–242. doi: 10.1002/(sici)1099-1573(199806)12:4<233::aid-ptr294>3.0.co;2-v
[29]
de Zwart FJ, Slow S, Payne RJ, Lever M, George PM, et al. (2003) Glycine betaine and glycine betaine analogues in common foods. Food Chem 83: 197–204. doi: 10.1016/s0308-8146(03)00063-3
[30]
De Roos B, Meyboom S, Kosmeijer-Schuil TG, Katan MB (1998) Absorption and urinary excretion of the coffee diterpenes cafestol and kahweol in healthy ileostomy volunteers. J Intern Med 244: 451–460. doi: 10.1046/j.1365-2796.1998.00386.x
[31]
Silva JA, Borges N, Santos A, Alves A (2012) Method Validation for Cafestol and Kahweol Quantification in Coffee Brews by HPLC-DAD. Food Analytical Methods 5: 1404–1410. doi: 10.1007/s12161-012-9387-5
[32]
Monteiro M, Farah A, Perrone D, Trugo LC, Donangelo C (2007) Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr 137: 2196–2201.
[33]
Nagy K, Redeuil K, Williamson G, Rezzi S, Dionisi F, et al. (2011) First identification of dimethoxycinnamic acids in human plasma after coffee intake by liquid chromatography-mass spectrometry. J Chromatogr A 1218: 491–497. doi: 10.1016/j.chroma.2010.11.076
[34]
Ito H, Gonthier M-P, Manach C, Morand C, Mennen L, et al. (2005) Polyphenol levels in human urine after intake of six different polyphenol-rich beverages. Br J Nutr 94: 500–509. doi: 10.1079/bjn20051522
[35]
Mennen L, Sapinho D, Ito H, Galan P, Hercberg S, et al. (2006) Urinary flavonoids and phenolic acids as biomarkers of intake for polyphenol-rich foods. Br J Nutr 96: 191–198. doi: 10.1079/bjn20061808
[36]
Stalmach A, Mullen W, Barron D, Uchida K, Yokota T, et al. (2009) Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab Dispos 37: 1749–1758. doi: 10.1124/dmd.109.028019
[37]
Lees HJ, Swann JR, Wilson ID, Nicholson JK, Holmes E (2013) Hippurate: The natural history of a mammalian-microbial cometabolite. J Proteome Res 12: 1527–1546. doi: 10.1021/pr300900b
[38]
Obatomi DK, Bach PH (1998) Biochemistry and toxicology of the diterpenoid glycoside atractyloside. Food Chem Toxicol 36: 335–346. doi: 10.1016/s0278-6915(98)00002-7
[39]
Garrett R, Schmidt EM, Pereira LFP, Kitzberger CSG, Scholz MBS, et al. (2013) Discrimination of arabica coffee cultivars by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry and chemometrics. Lebensm Wiss Technol 50: 496–502.
[40]
Obermann H, Spiteller G (1976) Structures of coffee atractylosides. Chem Ber 109: 3450–3461. doi: 10.1002/cber.19761091024
[41]
Llorach R, Urpi-Sarda M, Jauregui O, Monagas M, Andres-Lacueva C (2009) An LC-MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption. J Proteome Res 8: 5060–5068. doi: 10.1021/pr900470a
[42]
Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, et al. (2009) Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 5: 435–458. doi: 10.1007/s11306-009-0168-0
